Öberg K - Search Results

1

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.

Kanakis G, Grimelius L, Spathis A, Tringidou R, Rassidakis GZ, Öberg K, Kaltsas G, Tsolakis AV. Kanakis G, et al. Among authors: oberg k. Neuroendocrinology. 2015;101(3):211-22. doi: 10.1159/000381061. Epub 2015 Feb 26. Neuroendocrinology. 2015. PMID: 25765100

2

Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids.

Giandomenico V, Cui T, Grimelius L, Öberg K, Pelosi G, Tsolakis AV. Giandomenico V, et al. Among authors: oberg k. J Mol Endocrinol. 2013 Nov 7;51(3):277-86. doi: 10.1530/JME-13-0144. Print 2013 Dec. J Mol Endocrinol. 2013. PMID: 23969981

3

Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers.

Daskalakis K, Kaltsas G, Öberg K, Tsolakis AV. Daskalakis K, et al. Among authors: oberg k. Neuroendocrinology. 2018;107(4):355-365. doi: 10.1159/000493944. Epub 2018 Sep 23. Neuroendocrinology. 2018. PMID: 30244255

4

Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.

Cui T, Tsolakis AV, Li SC, Cunningham JL, Lind T, Öberg K, Giandomenico V. Cui T, et al. Among authors: oberg k. Eur J Endocrinol. 2013 Jan 17;168(2):253-61. doi: 10.1530/EJE-12-0814. Print 2013 Feb. Eur J Endocrinol. 2013. PMID: 23184910

5

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Koumarianou A, Kaltsas G, Kulke MH, Oberg K, Strosberg JR, Spada F, Galdy S, Barberis M, Fumagalli C, Berruti A, Fazio N. Koumarianou A, et al. Among authors: oberg k. Neuroendocrinology. 2015;101(4):274-88. doi: 10.1159/000430816. Epub 2015 Apr 29. Neuroendocrinology. 2015. PMID: 25924937 Review.

6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.

Oberg K, Ferone D, Kaltsas G, Knigge UP, Taal B, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Oberg K, et al. Neuroendocrinology. 2009;90(2):209-13. doi: 10.1159/000183751. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19077379 No abstract available.

7

Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.

Kanakis G, Kaltsas G, Granberg D, Grimelius L, Papaioannou D, Tsolakis AV, Öberg K. Kanakis G, et al. Among authors: oberg k. J Clin Endocrinol Metab. 2012 Apr;97(4):E627-31. doi: 10.1210/jc.2011-2592. Epub 2012 Feb 8. J Clin Endocrinol Metab. 2012. PMID: 22319031

8

Malignant gastric ghrelinoma with hyperghrelinemia.

Tsolakis AV, Portela-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, Oberg KE, Janson ET. Tsolakis AV, et al. Among authors: oberg ke. J Clin Endocrinol Metab. 2004 Aug;89(8):3739-44. doi: 10.1210/jc.2003-032118. J Clin Endocrinol Metab. 2004. PMID: 15292299

9

Gastric carcinoid in a patient infected with Helicobacter pylori: a new entity?

Antonodimitrakis P, Tsolakis A, Welin S, Kozlovacki G, Oberg K, Granberg D. Antonodimitrakis P, et al. Among authors: oberg k. World J Gastroenterol. 2011 Jul 7;17(25):3066-8. doi: 10.3748/wjg.v17.i25.3066. World J Gastroenterol. 2011. PMID: 21799655 Free PMC article.

10

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.

Welin S, Stridsberg M, Cunningham J, Granberg D, Skogseid B, Oberg K, Eriksson B, Janson ET. Welin S, et al. Among authors: oberg k. Neuroendocrinology. 2009;89(3):302-7. doi: 10.1159/000179900. Epub 2009 Jan 29. Neuroendocrinology. 2009. PMID: 19176944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters